These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9876508)

  • 1. Particle size distributions from multiparticulate dissolution.
    Dali MV; Carstensen JT
    Drug Dev Ind Pharm; 1998 Jul; 24(7):637-44. PubMed ID: 9876508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling dissolution of sparingly soluble multisized powders.
    de Almeida LP; Simöes S; Brito P; Portugal A; Figueiredo M
    J Pharm Sci; 1997 Jun; 86(6):726-32. PubMed ID: 9188056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental determination of the diffusion boundary layer width of micron and submicron particles.
    Galli C
    Int J Pharm; 2006 Apr; 313(1-2):114-22. PubMed ID: 16529883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
    Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth.
    Lindfors L; Skantze P; Skantze U; Westergren J; Olsson U
    Langmuir; 2007 Sep; 23(19):9866-74. PubMed ID: 17696457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an active pharmaceutical ingredient by its dissolution properties: amoxicillin trihydrate as a model drug.
    Horkovics-Kovats S
    Chemotherapy; 2004 Nov; 50(5):234-44. PubMed ID: 15528889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size distribution effects in multiparticulate dissolution.
    Pedersen PV; Brown KF
    J Pharm Sci; 1975 Dec; 64(12):1981-86. PubMed ID: 1206494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of mass transfer dissolution rate constants from critical time of dissolution of a powder sample.
    Carstensen JT; Dali M
    Pharm Dev Technol; 1999 Jan; 4(1):1-8. PubMed ID: 10027207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.
    Allahham A; Stewart PJ
    Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of powder polydispersity on aerosol generation.
    Chew NY; Chan HK
    J Pharm Pharm Sci; 2002; 5(2):162-8. PubMed ID: 12207868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of dissolution of powdered Pentelic marble in under-saturated solutions: the role of particle characteristics.
    Orkoula MG; Koutsoukos PG
    J Colloid Interface Sci; 2003 Mar; 259(2):287-92. PubMed ID: 16256508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sieve cuts as monodisperse powders in dissolution studies.
    Brooke D
    J Pharm Sci; 1975 Aug; 64(8):1409-12. PubMed ID: 1151719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of artificial gastric juice composition on bioaccessibility of cobalt- and tungsten-containing powders.
    Stefaniak AB; Virji MA; Harvey CJ; Sbarra DC; Day GA; Hoover MD
    Int J Hyg Environ Health; 2010 Mar; 213(2):107-15. PubMed ID: 20096630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical characteristics of Glycyrrhizae radix micropowder].
    Liu L; Wu LP; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1079-81. PubMed ID: 20501399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution patterns of polydisperse powders: oxalic acid dihydrate.
    Carstensen JT; Patel M
    J Pharm Sci; 1975 Nov; 64(11):1770-6. PubMed ID: 1195106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
    Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
    Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of particle size distribution on an experimental glass-ionomer cement.
    Prentice LH; Tyas MJ; Burrow MF
    Dent Mater; 2005 Jun; 21(6):505-10. PubMed ID: 15904692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.